856696-06-5

Basic information

• Product Name: 1,1-dimethylethyl [(1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(tetrahydro-2H-pyran-4-ylamino)propyl]-carbamate
• Synonyms: 1,1-dimethylethyl [(1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(tetrahydro-2H-pyran-4-ylamino)propyl]-carbamate
• CAS NO: 856696-06-5
• Molecular Weight: 364.485
• Mol File: 856696-06-5.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 1,1-dimethylethyl [(1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(tetrahydro-2H-pyran-4-ylamino)propyl]-carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: 1,1-dimethylethyl [(1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(tetrahydro-2H-pyran-4-ylamino)propyl]-carbamate(856696-06-5)
• EPA Substance Registry System: 1,1-dimethylethyl [(1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(tetrahydro-2H-pyran-4-ylamino)propyl]-carbamate(856696-06-5)

Safety Data

• Hazardous Substances Data: 856696-06-5(Hazardous Substances Data)

Upstream product

• 38041-19-9 4-aminotetrahydropyran 
• 98760-08-8 (1-oxiranyl-2-phenylethyl)carbamic acid tert-butyl ester 

Relevant articles and documents

TRICYCLIC INDOLE DERIVATIVES FOR USE IN THE TREATMENT OF ALZHEIMER’S DISEASE

The present invention relates to novel ketone compounds of formula (I) having Asp2 (β-secretase, BACE1 or Memapsin-2) inhibitory activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases chara

HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE

The present invention relates to novel hydroxyethylamine compounds of formula (I): (I) having Asp2 (-secretase, BACE1 or Memapsin) inhibitory activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by elevated-amyloid levels or-amyloid deposits, particularly Alzheimer's disease.